CRLBF, GTBIF, OTC, Tickers, VRNOF #Medical Condition Cannabis #Third-Party Articles Third-Party Article Betting on Marijuana Legalization Bill? Analysts Suggest 3 Stocks to Buy November 14, 2021 13:19 EST You don’t normally think of Federal regulation – or the prospect of Federal regulation – being the catalyst for sudden, industry-wide, spike in share prices. But that’s exactly what we’re seeing with cannabis stocks right now, as a House Republican has submitted a draft bill on Federal legalization – No Comments
FLWPF, OTC, Tickers #Financials Earnings #Medical Condition Cannabis The Flowr Corporation Announces Third Quarter 2021 Earnings Date November 12, 2021 17:30 EST TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) announces that the Company will release its third quarter results before the opening of financial markets on Monday, November 29, 2021. About The Flowr Corporation The Flowr Corporation is a No Comments
ACB, NYSE, Tickers #IR Meeting Results #Medical Condition Cannabis Aurora Cannabis Announces Results of 2021 Annual General Meeting November 12, 2021 17:20 EST NASDAQ | TSX: ACB EDMONTON, AB, Nov. 12, 2021 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the “Meeting“) held on Friday, No Comments
AYRWF, OTC, Tickers #Medical Condition Cannabis #Shares Senior Notes Ayr Wellness Adds US$150 Million to Balance Sheet with Sale of Additional Senior Secured Notes November 12, 2021 16:22 EST MIAMI, Nov. 12, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a vertically-integrated cannabis multi-state operator (MSO), today announced the addition of approximately US$150 million to its balance sheet following the sale of additional 12.5% Senior Secured Notes (the “Notes”). The No Comments
AAWH, ACB, ACRDF, AGFY, ALEAF, AVCNF, CCHWF, CLVR, CLVRW, CNBS, CRLBF, CRON, CURLF, EXPFF, FORA, GDNSF, GHBWF, GLASF, GRWG, HERTF, HYFM, IGXT, JAZZ, KERN, LBLCF, MAPS, MJ, MMNFF, MSOS, NASDAQ, NVACF, NYSE, OTC, SNDL, SPY, SRNA, TCAC, THCX, Tickers, UGRO, VFF, VLNCF, VRNOF, YOLO, ZDPY #Financials Earnings #Medical Condition Cannabis #Third-Party Articles Third-Party Article The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman’s Campaign November 12, 2021 14:35 EST Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021. Contents Earnings Season Analyst Reactions GOP Lawmakers Present Cannabis Legalization Bill Seth Rogen, Sarah Silverman, Marijuana Giants Launch Initiative Urging Congress To Legalize Pot Texas Judge Blocks No Comments
ACB, NASDAQ, NYSE, SNDL, Tickers #Medical Condition Cannabis #Shares Buyback #Third-Party Articles Positive Movement Explanation Why Aurora Cannabis Stock Is Trading Higher Today November 12, 2021 14:14 EST Aurora Cannabis Inc (NASDAQ: ACB) is trading higher Friday in sympathy with Sundial Growers Inc (NASDAQ: SNDL), which reported its third-quarter financial results and announced a share repurchase program. Sundial reported quarterly net earnings of $11.3 million Canadian dollars ($8.99 million), which is up from a loss of CAD$71.4 No Comments
NASDAQ, SNDL, Tickers #Financials Positive #Medical Condition Cannabis #Shares Buyback #Third-Party Articles Positive Movement Explanation Why Sundial Growers Shares Are Trading Higher Today November 12, 2021 12:26 EST Sundial Growers Inc (NASDAQ: SNDL) is trading higher Friday after the company reported its third-quarter financial results and announced a share repurchase program. Sundial reported quarterly net earnings of $11.3 million Canadian dollars ($8.99 million), which is up from a loss of CAD$71.4 million year-over-year. The company reported quarterly No Comments
OTC, RTSL, Tickers #Events Upcoming #Medical Condition Cannabis Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference November 12, 2021 09:15 EST DALLAS, Nov. 12, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic” or the “Company”), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that Chief Executive Officer Donal Schmidt will present a corporate overview at the Q4 Investor Summit No Comments
ANEB, NASDAQ, Tickers #Financials Data #Medical Condition Cannabis Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update November 12, 2021 08:00 EST AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction, today announced financial results for the first quarter of its fiscal year ending June 30, 2022 and reported recent business highlights. Highlights for the quarter No Comments
AVCNF, OTC, Tickers #Financials Data #Medical Condition Cannabis Avicanna Announces Filing of Interim Financial Statements for the Three-Month Period Ending September 30, 2021, Demonstrating Progressive Commercialization Results November 12, 2021 07:30 EST Record gross revenue of $1,007,033 through steady growth and progression of global commercialization Delivered a record number (27,041) of units of cannabis 2.0 products globally, an increase of 61% from Q2 25 listings of cannabis 2.0 products across adult use and medical channels in Canada. Expanded into and No Comments
STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace) 01/23/2023
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress 01/23/2023